Skip to main content
. 2021 Mar 31;11:644840. doi: 10.3389/fonc.2021.644840

Figure 1.

Figure 1

The expression of ACSM3 and its co-relation of the overall survival of ovarian cancer. (A) Boxplot of ACSM3 in ovarian cancer. TPM, transcripts per kilobase of exon model per million mapped reads. (B) Overall survival time between patients with high and low ACSM3 expression. Dotted lines indicated the 95% confidence interval. HR, hazard ratio. (C) Relative protein expression of ACSM3 in ovarian epithelial cells and ovarian cancer cells: OV-90, SK-OV-3, OVCAR-3, and A2780 cells. (D) Relative protein expression of ACSM3 in Lv-shRNA-ACSM3 infected OV-90 cells (E) Relative protein expression of ACSM3 in Lv-ACSM3 infected A2780 or SK-OV-3 cells. Measurement data were expressed as mean ± SD of three independent experiments. ^^p < 0.01 versus ovarian epithelial cells; *p < 0.05, **p < 0.01 versus Lv-shRNA-NC; ## p < 0.01 versus Lv-Vector.